Madoka Ito

426 total citations
27 papers, 332 citations indexed

About

Madoka Ito is a scholar working on Epidemiology, Surgery and Molecular Biology. According to data from OpenAlex, Madoka Ito has authored 27 papers receiving a total of 332 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Epidemiology, 7 papers in Surgery and 5 papers in Molecular Biology. Recurrent topics in Madoka Ito's work include Liver Disease Diagnosis and Treatment (5 papers), Amino Acid Enzymes and Metabolism (3 papers) and Drug-Induced Hepatotoxicity and Protection (3 papers). Madoka Ito is often cited by papers focused on Liver Disease Diagnosis and Treatment (5 papers), Amino Acid Enzymes and Metabolism (3 papers) and Drug-Induced Hepatotoxicity and Protection (3 papers). Madoka Ito collaborates with scholars based in Japan, Australia and United States. Madoka Ito's co-authors include Isao Ishiguro, Yoichi Nagamura, Toshiharu Nagatsu, Keisuke Fujita, Makoto Okumura, Hiroshi Suzuki, Chisato Hirayama, Setsuo Saito, Fumio Mizuno and Shuji Hashimoto and has published in prestigious journals such as Analytical Biochemistry, FEBS Letters and Journal of Nutrition.

In The Last Decade

Madoka Ito

22 papers receiving 316 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Madoka Ito Japan 10 155 64 45 36 29 27 332
K Menzel Germany 5 171 1.1× 55 0.9× 36 0.8× 49 1.4× 15 0.5× 5 356
Emanuela Astori Italy 10 163 1.1× 53 0.8× 44 1.0× 31 0.9× 22 0.8× 13 440
C. J. Beukelman Netherlands 8 106 0.7× 42 0.7× 73 1.6× 41 1.1× 18 0.6× 12 410
Anjan Basak India 7 151 1.0× 22 0.3× 46 1.0× 26 0.7× 28 1.0× 12 398
Manuela Sanna Italy 15 111 0.7× 29 0.5× 39 0.9× 73 2.0× 20 0.7× 40 592
Mari Nakayama Japan 9 273 1.8× 36 0.6× 46 1.0× 41 1.1× 19 0.7× 14 507
P J Kerry United Kingdom 11 88 0.6× 68 1.1× 41 0.9× 12 0.3× 18 0.6× 27 344
Manju Mukherjea India 11 203 1.3× 46 0.7× 37 0.8× 12 0.3× 35 1.2× 52 510
M. Menzione Italy 13 155 1.0× 38 0.6× 77 1.7× 12 0.3× 19 0.7× 24 448
Luka Andrišić Croatia 11 151 1.0× 40 0.6× 35 0.8× 16 0.4× 35 1.2× 19 478

Countries citing papers authored by Madoka Ito

Since Specialization
Citations

This map shows the geographic impact of Madoka Ito's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Madoka Ito with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Madoka Ito more than expected).

Fields of papers citing papers by Madoka Ito

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Madoka Ito. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Madoka Ito. The network helps show where Madoka Ito may publish in the future.

Co-authorship network of co-authors of Madoka Ito

This figure shows the co-authorship network connecting the top 25 collaborators of Madoka Ito. A scholar is included among the top collaborators of Madoka Ito based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Madoka Ito. Madoka Ito is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Matsuda, Yoshinobu, Masanori Mori, Akihiro Tokoro, et al.. (2025). Minimal Clinically Important Difference in the Integrated Palliative Care Outcome Scale for Cancer Dyspnea. Journal of Pain and Symptom Management. 70(4). 335–340.
2.
Emoto, Ken, Masahiro Sakai, Madoka Ito, et al.. (2023). Crowned dens syndrome: A case series of 72 patients at eight teaching hospitals in Japan. Journal of General and Family Medicine. 24(3). 171–177. 4 indexed citations
3.
Matsunuma, Ryo, et al.. (2023). Malodour from oral malignant fungating wound: sprayed metronidazole – case report. BMJ Supportive & Palliative Care. 13(e3). e966–e967.
4.
Emoto, Ken, Masahiro Sakai, Madoka Ito, et al.. (2023). Author reply to “How to distinguish crowned dens syndrome from acute meningitis?”. Journal of General and Family Medicine. 24(6). 356–357.
5.
Ito, Madoka, et al.. (2022). Risk factors for mortality in aspiration pneumonia: a single-center retrospective observational study. Monaldi Archives for Chest Disease. 93(3).
6.
Taniguchi, Yoshihiko, Yoshinobu Matsuda, Masanori Mori, et al.. (2022). Effectiveness and safety of opioids for dyspnea in patients with lung cancer: secondary analysis of multicenter prospective observational study. Translational Lung Cancer Research. 11(12). 2395–2402. 3 indexed citations
7.
Ohashi, Kazuki, et al.. (2021). Evaluation of and Intervention for Sarcopenia in Hepatology Departments: A Survey of Nurses in Japan. Healthcare. 9(8). 1021–1021. 3 indexed citations
8.
Ito, Madoka, et al.. (2017). Mild Encephalitis/Encephalopathy with a Reversible Splenial Lesion in an Adult Patient with Influenza. Internal Medicine. 56(22). 3093–3095. 10 indexed citations
9.
Kojima, Shigeko, Hiroki Sakakibara, Kunihiko Hirose, et al.. (2005). Effects of Smoking and Age on Chronic Obstructive Pulmonary Disease in Japan. Journal of Epidemiology. 15(4). 113–117. 28 indexed citations
10.
Hirayama, Chisato, et al.. (2003). Propagermanium: a nonspecific immune modulator for chronic hepatitis B. Journal of Gastroenterology. 38(6). 525–532. 47 indexed citations
11.
Yasuda, Kiyomi, Yasuo Ohashi, T Matsushima, et al.. (2000). Low-dose oral interferon-α in the treatment of chronic viral hepatitis type B: A double-blind, randomized, placebo-controlled, clinical trial. Current Therapeutic Research. 61(5). 245–254. 2 indexed citations
12.
Hirata, M., Kenji Sano, K Kusaka, et al.. (1999). Recovery of renal function after living-related liver transplantation in a case of hepatitis B virus liver cirrhosis with renal failure. Transplantation Proceedings. 31(7). 2904–2905. 1 indexed citations
13.
Hotta, Nigishi, Jiro Nakamura, Keigo Yasuda, et al.. (1999). Effects of the 5-HT2A Receptor Antagonist Sarpogrelate in Diabetic Patients with Complications. Clinical Drug Investigation. 18(3). 199–207. 13 indexed citations
14.
Nobori, Tsutomu, et al.. (1997). In vitro effects of Sho-saiko-to on production of granulocyte colony-stimulating factor by mononuclear cells from patients with chronic hepatitis C. International Journal of Immunopharmacology. 19(7). 381–385. 16 indexed citations
15.
Ito, Madoka, et al.. (1996). Conversion of γ-glutamylcysteinylethyl ester to glutathione in rat hepatocytes. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1313(1). 47–53. 31 indexed citations
17.
Nagamura, Yoichi, et al.. (1986). Cholesterol uptake of isolated rat hepatocytes is accelerated by several kinds of phosphatidylcholine. FEBS Letters. 203(1). 91–94. 2 indexed citations
18.
Kubota, Kensuke, Kazuhiro Yamada, Hiroyuki Fukuda, et al.. (1982). Tumor Detection with Carbon-11-Labeled Amino Acids. 1982(1982). 135–141. 2 indexed citations
19.
Fujita, Keisuke, et al.. (1976). Urinary putrescine, spermidine, and spermine in human blood and solid cancers and in an experimental gastric tumor of rats.. PubMed. 36(4). 1320–4. 67 indexed citations
20.
Kato, Katsumoto, et al.. (1973). Clinical investigation on glucose tolerance in liver cirrhosis.. PubMed. 35(2). 91–101. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026